Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
17.53
+0.75 (4.47%)
At close: Jun 18, 2026, 4:00 PM EDT
17.70
+0.17 (0.97%)
After-hours: Jun 18, 2026, 7:50 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.81 billion as of June 18, 2026. Its market cap has increased by 85.05% in one year.
Market Cap
2.81B
Enterprise Value
2.78B
1-Year Change
85.05%
Ranking
Category
Stock Price
$17.53
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.81B, a decrease of -41.24%. That is a compound annual growth rate of -7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.81B | 13.16% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 5.45B |
| BillionToOne | 4.84B |
| Sotera Health Company | 4.51B |
| Veracyte | 4.28B |
| RadNet | 4.23B |
| GRAIL | 2.74B |
| GeneDx Holdings | 1.75B |
| NeoGenomics | 1.45B |